Lupin Limited LUPIN

Latest filings

• General25 12 Nov, 11:38 · BSE
  Lupin Announces European Launch of Biosimilar Ranibizumab.
• Routine15 6 Nov, 20:38 · NSE
  Transcript of Q2 FY2027 Earnings Conference Call.
• Routine15 5 Nov, 16:38 · NSE
  Copies of Newspaper Publication regarding Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.
• Routine15 4 Nov, 21:18 · BSE
  Link of Audio recording of the Earnings Call-Q2 FY27.
• Routine15 4 Nov, 21:11 · NSE
  Link of Recording.
• Routine15 4 Nov, 01:52 · BSE
  Investor Presentation- Q2 FY2027
• Results73 4 Nov, 01:48 · BSE
  Lupin Q2 FY2027 Results
• Management change70 4 Nov, 01:14 · BSE
  Appointment of Mr. Akhil Gupta as an Additional Director (Non-Executive, Independent) effective November 03, 2026 and as an Independent Director for a term of five consecutive years with ....
• Management change70 4 Nov, 01:12 · NSE
  Change in Director(s) of the company.
• Results73 4 Nov, 24:44 · NSE
  , the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Shown 15 minutes after publication. Real time with Pro.